Malignant neoplasm of ovary
|
0.600 |
CausalMutation
|
disease |
CGI |
|
|
|
Malignant neoplasm of ovary
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Malignant neoplasm of ovary
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Ovarian Carcinoma
|
0.500 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Ovarian Carcinoma
|
0.500 |
CausalMutation
|
disease |
CGI |
|
|
|
ovarian neoplasm
|
0.400 |
CausalMutation
|
disease |
CGI |
|
|
|
ovarian neoplasm
|
0.400 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Neoplasm of uncertain or unknown behavior of ovary
|
0.300 |
CausalMutation
|
disease |
CGI |
|
|
|
Carcinoma, Ovarian Epithelial
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Noonan Syndrome 1
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Neoplasms
|
0.030 |
GeneticVariation
|
group |
BEFREE |
TC21 is a Ras-like GTPase with high oncogenic potential that is found mutated in some human tumors and overexpressed in breast cancer cell lines.
|
10557073 |
1999 |
Malignant neoplasm of breast
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
TC21 is a Ras-like GTPase with high oncogenic potential that is found mutated in some human tumors and overexpressed in breast cancer cell lines.
|
10557073 |
1999 |
Breast Carcinoma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
TC21 is a Ras-like GTPase with high oncogenic potential that is found mutated in some human tumors and overexpressed in breast cancer cell lines.
|
10557073 |
1999 |
Malignant Neoplasms
|
0.010 |
AlteredExpression
|
group |
BEFREE |
TC21 nuclear expression increased from normal oral tissues to leukoplakia and frank malignancy (P < 0.001).
|
20040018 |
2010 |
Primary malignant neoplasm
|
0.010 |
AlteredExpression
|
group |
BEFREE |
TC21 nuclear expression increased from normal oral tissues to leukoplakia and frank malignancy (P < 0.001).
|
20040018 |
2010 |
Leukoplakia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
TC21 overexpression was observed in 74.2% leukoplakia with no dysplasia, 75.9% dysplasias and 79.5% OSCCs in comparison with normal oral tissues.
|
20040018 |
2010 |
leiomyosarcoma
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
TC21 is a ras family member that shares close homology to H-, K- and N-ras, and activating mutations have been found in ovarian carcinoma and leiomyosarcoma cell lines.
|
9703274 |
1998 |
Adult Leiomyosarcoma
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
TC21 is a ras family member that shares close homology to H-, K- and N-ras, and activating mutations have been found in ovarian carcinoma and leiomyosarcoma cell lines.
|
9703274 |
1998 |
Childhood Leiomyosarcoma
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
TC21 is a ras family member that shares close homology to H-, K- and N-ras, and activating mutations have been found in ovarian carcinoma and leiomyosarcoma cell lines.
|
9703274 |
1998 |
leiomyosarcoma
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
A novel insertional mutation in the TC21 gene activates its transforming activity in a human leiomyosarcoma cell line.
|
7478545 |
1995 |
Adult Leiomyosarcoma
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
A novel insertional mutation in the TC21 gene activates its transforming activity in a human leiomyosarcoma cell line.
|
7478545 |
1995 |
Childhood Leiomyosarcoma
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
A novel insertional mutation in the TC21 gene activates its transforming activity in a human leiomyosarcoma cell line.
|
7478545 |
1995 |
Malignant neoplasm of breast
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
A polymorphism in the TC21 promoter associates with an unfavorable tamoxifen treatment outcome in breast cancer.
|
19047159 |
2008 |
Breast Carcinoma
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
A polymorphism in the TC21 promoter associates with an unfavorable tamoxifen treatment outcome in breast cancer.
|
19047159 |
2008 |
Malignant transformation
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
Aberrant function of RRAS2 drives malignant transformation in a various of cancers.
|
31517733 |
2019 |